BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34274383)

  • 1. Mitochondria-targeted vitamin E succinate delivery for reversal of multidrug resistance.
    Liang L; Peng Y; Qiu L
    J Control Release; 2021 Sep; 337():117-131. PubMed ID: 34274383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin.
    Wang J; Ma W; Guo Q; Li Y; Hu Z; Zhu Z; Wang X; Zhao Y; Chai X; Tu P
    Int J Nanomedicine; 2016; 11():5851-5870. PubMed ID: 27853369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimuli-responsive, dual-function prodrug encapsulated in hyaluronic acid micelles to overcome doxorubicin resistance.
    Qiu L; Xu J; Ahmed KS; Zhu M; Zhang Y; Long M; Chen W; Fang W; Zhang H; Chen J
    Acta Biomater; 2022 Mar; 140():686-699. PubMed ID: 34875359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Design of Multifunctional Polymeric Nanoparticles Based on Poly(l-histidine) and d-α-Vitamin E Succinate for Reversing Tumor Multidrug Resistance.
    Li Z; Chen Q; Qi Y; Liu Z; Hao T; Sun X; Qiao M; Ma X; Xu T; Zhao X; Yang C; Chen D
    Biomacromolecules; 2018 Jul; 19(7):2595-2609. PubMed ID: 29618203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy.
    Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z
    Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer.
    Mao J; Qiu L; Ge L; Zhou J; Ji Q; Yang Y; Long M; Wang D; Teng L; Chen J
    Biomed Pharmacother; 2021 Feb; 134():111108. PubMed ID: 33341670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
    Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y
    Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
    Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D
    Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-gp Inhibition and Mitochondrial Impairment by Dual-Functional Nanostructure Based on Vitamin E Derivatives To Overcome Multidrug Resistance.
    Tuguntaev RG; Chen S; Eltahan AS; Mozhi A; Jin S; Zhang J; Li C; Wang PC; Liang XJ
    ACS Appl Mater Interfaces; 2017 May; 9(20):16900-16912. PubMed ID: 28463476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
    Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z
    J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multifunctional nano-delivery system enhances the chemo-
    Zhao R; Ning X; Wang M; Yu A; Wang Y
    J Mater Chem B; 2021 Nov; 9(44):9174-9182. PubMed ID: 34698329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated phospholipid micelles containing D-α-tocopheryl succinate as multifunctional nanocarriers for enhancing the antitumor efficacy of doxorubicin.
    Jiang W; Fan Q; Wang J; Zhang B; Hao T; Chen Q; Li L; Chen L; Cui H; Li Z
    Int J Pharm; 2021 Sep; 607():120979. PubMed ID: 34371151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination Therapy of Doxorubicin and Quercetin on Multidrug-Resistant Breast Cancer and Their Sequential Delivery by Reduction-Sensitive Hyaluronic Acid-Based Conjugate/d-α-Tocopheryl Poly(ethylene glycol) 1000 Succinate Mixed Micelles.
    Liu S; Li R; Qian J; Sun J; Li G; Shen J; Xie Y
    Mol Pharm; 2020 Apr; 17(4):1415-1427. PubMed ID: 32159961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid/dextran-based polymeric micelles co-delivering ursolic acid and doxorubicin to mitochondria for potentiating chemotherapy in MDR cancer.
    Guo Y; Yang X; Zhang Y; Luo F; Yang J; Zhang X; Mi J; Xie Y
    Carbohydr Polym; 2024 May; 332():121897. PubMed ID: 38431408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer.
    Yuan Z; Yuan Y; Han L; Qiu Y; Huang X; Gao F; Fan G; Zhang Y; Tang X; He X; Xu K; Yin P
    Int J Nanomedicine; 2018; 13():7533-7548. PubMed ID: 30532537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo.
    Wang J; Li Y; Wang L; Wang X; Tu P
    Drug Deliv; 2018 Nov; 25(1):330-340. PubMed ID: 29350064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle delivery of a pH-sensitive prodrug of doxorubicin and a mitochondrial targeting VES-H
    Czupiel P; Delplace V; Shoichet M
    Sci Rep; 2020 May; 10(1):8726. PubMed ID: 32457422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells.
    Zhong XC; Xu WH; Wang ZT; Guo WW; Chen JJ; Guo NN; Wang TT; Lin MT; Zhang ZT; Lu YY; Yang QY; Han M; Xu DH; Gao JQ
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1556-1564. PubMed ID: 31271317
    [No Abstract]   [Full Text] [Related]  

  • 20. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
    Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
    Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.